NCT00009178

Treatment of Bulimia Nervosa in a Primary Care Setting

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: —
• Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · NIH
• Sex: Female
• Age: 18 Years – 60 Years
• Healthy volunteers: Not accepted

Summary

Bulimia Nervosa is a frequent problem for young women. It is widely assumed that this disorder cannot be treated effectively in a primary care setting. This assumption has never been tested empirically, and is probably incorrect. In the last 15 years, effective treatment interventions for Bulimia Nervosa have been developed and validated in specialized treatment centers. The broad aim of this proposal is to examine whether these treatments, suitably adapted, can be usefully transferred to general health care settings. Specifically, the proposed study will determine the relative and combined effectiveness of the two leading treatments for Bulimia Nervosa in a primary care setting. The two major interventions are treatment with an antidepressant medication, fluoxetine, and with a form of cognitive behavioral therapy, guided self-help, designed for use in primary care.

Conditions

• Bulimia Nervosa

Interventions

Type	Name	Description
DRUG	Fluoxetine
BEHAVIORAL	Guided Self-Help

Timeline

• Start date: 1998-03-01
• Completion: 2001-12-01
• First posted: 2001-01-23
• Last updated: 2010-01-14

Locations

1 site across 1 country: United States